Flecainide in Treating Patients With Chronic Neuropathic Pain

Phase 2 Completed 20 enrolled Eastern Cooperative Oncology Group National Cancer Institute (NCI) · collab

Supportive care

Summary

RATIONALE: Flecainide therapy may help patients with neuropathic pain live more comfortably. PURPOSE: Phase II trial to study the effectiveness of flecainide in treating patients with chronic neuropathic pain from cancer or AIDS.

Timeline

Start: 1998-05-04
Primary completion: 2006-04
Completion: —

Publications

Results von Gunten CF, Eappen S, Cleary JF, Taylor SG 4th, Moots P, Regevik N, Cleeland C, Cella D. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliat Med. 2007 Dec;21(8):667-72. doi: 10.1177/0269216307083031.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	flecainide	Small molecule	100 mg	—

Indications

No indication recorded.